Recent RENB News
- Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics • GlobeNewswire Inc. • 04/30/2024 03:00:00 PM
- RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership • GlobeNewswire Inc. • 04/24/2024 01:00:00 PM
- Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Ca • GlobeNewswire Inc. • 04/18/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:03:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 08:20:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:01:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:35:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:17:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:20:42 PM
- Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace • GlobeNewswire Inc. • 02/15/2024 02:25:00 PM
- Statement of Renovaro Inc • GlobeNewswire Inc. • 02/14/2024 03:01:30 PM
- Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace • GlobeNewswire Inc. • 02/13/2024 02:46:07 PM
- AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine • GlobeNewswire Inc. • 02/13/2024 02:31:09 PM
- Renovaro Biosciences Announces Results of Special Meeting of Shareholders • GlobeNewswire Inc. • 01/25/2024 05:45:00 PM
- Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors • GlobeNewswire Inc. • 10/11/2023 01:25:00 PM
- Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors • GlobeNewswire Inc. • 10/10/2023 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:34:03 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 10/06/2023 08:30:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:20:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:15:17 PM
- Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD • GlobeNewswire Inc. • 10/02/2023 04:05:40 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM